← FDA Drug Approvals (Drugs@FDA)

EPIRUBICIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2007-10-22

Drug application

FDA Application #
ANDA065361
Application type
Abbreviated New Drug Application (Generic)
Brand name
EPIRUBICIN HYDROCHLORIDE
Generic name
Epirubicin Hydrochloride
Active ingredients
EPIRUBICIN HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
CIPLA LTD
First approval
2007-10-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown